Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
Public ClinicalTrials.gov record NCT00659347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 in Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of this placebo-controlled trial are to evaluate effectiveness and safety of DOV 21,947 at two oral dose levels.
Study identification
- NCT ID
- NCT00659347
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2008 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Dec 5, 2008
2008
United States locations
- U.S. sites
- 10
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Psychiatric Care | Norwich | Connecticut | 06360 | — |
| Future Care Studies | Springfield | Massachusetts | 01103 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| CRI Worldwide, LLC | Clementon | New Jersey | 08021 | — |
| Princeton Medical Institute | Princeton | New Jersey | 08540 | — |
| Brooklyn Medical Institute | Brooklyn | New York | 11223 | — |
| Social Psychiatry Research Institute | New York | New York | 10021 | — |
| Richmond Behavorial Associates | Staten Island | New York | 10312 | — |
| CRI Worldwide, LLC | Philadelphia | Pennsylvania | 19139 | — |
| Scranton Medical Institutes | Scranton | Pennsylvania | 18503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00659347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2008 · Synced Oct 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00659347 live on ClinicalTrials.gov.